As of April 30, 2025, Adial Pharmaceuticals (ADIL) has a market cap of $4.512 million USD. According to our data, Adial Pharmaceuticals is ranked No.9039 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 30, 2025 | $4.51 M |
-31.00%
|
Dec 31, 2024 | $6.54 M |
-45.70%
|
Dec 29, 2023 | $12.04 M |
-66.18%
|
Dec 30, 2022 | $35.61 M |
-91.85%
|
Dec 31, 2021 | $0.44 B |
58.82%
|
Dec 31, 2020 | $0.28 B |
-29.46%
|
Dec 31, 2019 | $0.39 B |
-52.93%
|
Dec 31, 2018 | $0.83 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Alkermes
ALKS
|
$4.74 B |
0.000 M
|
![]() Ireland
|
![]() BioXcel Therapeutics
BTAI
|
$10.88 M |
0.000 M
|
![]() USA
|
![]() Corcept Therapeutics
CORT
|
$7.77 B |
-0.000 M
|
![]() USA
|
![]() Intra-Cellular Therapies
ITCI
|
$14.05 B |
0.000 M
|
![]() USA
|
![]() Minerva Neurosciences
NERV
|
$12.06 M |
0.000 M
|
![]() USA
|
![]() Sage Therapeutics
SAGE
|
$0.48 B |
-0.000 M
|
![]() USA
|
![]() Supernus Pharmaceuticals
SUPN
|
$1.81 B |
0.000 M
|
![]() USA
|
![]() Tonix Pharmaceuticals
TNXP
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() Vanda Pharmaceuticals
VNDA
|
$0.26 B |
0.000 M
|
![]() USA
|
![]() Axsome Therapeutics
AXSM
|
$5.36 B |
0.000 M
|
![]() USA
|
![]() Cassava Sciences
SAVA
|
$75.36 M |
-0.000 M
|
![]() USA
|
![]() Relmada Therapeutics
RLMD
|
$9.43 M |
0.000 M
|
![]() USA
|
![]() VistaGen Therapeutics
VTGN
|
$66.09 M |
0.000 M
|
![]() USA
|
Market Cap | = | ADIL Stock Price | * | ADIL Shares Outstanding |
= | $0.69 | * | 6.57 M | |
= | $4.51 M |